Skip to main content Skip to main navigation
Government logo | to homepage Rijksinstituut voor Volksgezondheid en Milieu Ministerie van Volksgezondheid,
Welzijn en Sport
  • EN
  • NL
  • Home
  • Gene Therapy Office
    • History
    • Overview of assessment bodies
    • Assessment procedures
    • Tips for the applicant
  • Preliminary consult
    • Assessment frameworks
    • Preparation by the investigator
    • Organisation
  • Application form
    • Part A: Biosafety aspects
    • Part B: Patient-related aspects
    • Application forms
  • Ongoing study
    • What to do in the event of changes to the research
    • What to do in the event of adverse events and unexpected circumstances
    • Periodic reports and notifications
  • Links
  • FAQ
  • Home
  • News

News

Requirement applications for deliberate release of gmo’s application for COVID-19 clinical trials COVID-19 is temporarily suspended

On July 17 2020 the European Commission published a regulation that a day later, on 2020, July 18 took effect .

07/21/2020 - 14:16

From 13 March 2020, submission of research dossiers for gene therapy and medicinal products containing GMOs takes place directly to the relevant authority

From 13 March 2020, research dossiers in the field of gene therapy and medicinal products containing GMOs must be submitted directly to the relevant authority (CCMO as review committee, Ministry o

03/16/2020 - 20:20

Amendment to the 'Wet Milieubeheer' and the GMO Decree (cancellation of 6-week waiting period)

As of July 1, 2019, after receiving a permit of the ministry of Infrastructure and Water Management, you no longer have to wait 6 weeks before you can start the activities.

07/02/2019 - 13:18

Filter

Fill in your search phrase.

Show filters

Service

  • Contact
  • RIVM.nl
  • Archive

Over deze site

  • Sitemap
  • Cookies
  • Proclaimer
  • Responsible disclosure
  • Privacy